Biomea Fusion Inc
NASDAQ:BMEA 9:44:13 AM EDT
Biomea Fusion Inc Stock, NASDAQ:BMEA
900 Middlefield Road, 4th Floor, Redwood City, California 94063
United States of America
Phone: +1.650.980.9099
Number of Employees: 103
Description
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.